Companies: 10,795·Total market cap: $144.5T
BELLUS Health Inc.

BELLUS Health Inc.

BLUNASDAQHealthcare
$14.75
+$0.01(+0.03%)
Market Cap$1.9B
P/E Ratio
52W High$14.76
52W Low$6.38

BELLUS Health Inc.(BLU)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

blu · 股价预测 · 6 位分析师(近3月)· FMP · 更新于 2024年4月26日

分析师评级与共识

基于过去 3 个月内 6 位华尔街分析师

SellBuy

Hold

6 位分析师

共识

评级分布

Strong Buy
0
Buy
2
Hold
4
Sell
0
Strong Sell
0
合计: 6 · 买入占比: 33.3%

12 个月目标价

High

$14.75

Consensus

$14.75

+0.1% upside

Low

$14.75

Median: $14.75 · Last Close: $14.74

BELLUS Health Inc.(BLU)的分析师共识为 Hold,基于过去 3 个月内 6 位华尔街分析师的评级。BLU 的 12 个月平均目标价为 $14.75,相对当前价 $14.74 代表 +0.1% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$14.770.20%

1-day model range: $14.76–$14.78. Peak: $14.78 (+0.20%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

57%36%7%
8Buy
5Neutral
1Sell
RSI (14)72.7Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · BLU · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$14.74NEUTRAL
MA 10$14.70BUY
MA 20$14.64BUY
MA 50$14.55BUY
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $BLU · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$14.73BUY
EMA 10$14.70BUY
EMA 20$14.65BUY
EMA 50$14.55BUY
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $BLU · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
RBC Capital2023-05-15
Maintains
Sector PerformPerform
RBC Capital2023-05-14
Maintains
Sector PerformPerform
RBC Capital2023-04-19
Downgrade ↓
OutperformPerform
Jefferies2023-04-19
Downgrade ↓
BuyHold
Jefferies2023-04-18
Downgrade ↓
BuyHold
RBC Capital2023-04-18
Downgrade ↓
OutperformPerform
Evercore ISI Group2023-04-18
Downgrade ↓
OutperformIn Line
Evercore ISI Group2023-04-17
Downgrade ↓
OutperformIn Line
RBC Capital2022-09-30
Maintains
OutperformOutperform
RBC Capital2022-09-29
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on BELLUS Health Inc. (BLU) stock. Of the recent 32 rating actions, 0 were upgrades and 8 were downgrades. 6 analysts currently cover BLU.

分析师推荐趋势

Buy ratings202
Hold ratings02↑ +2
Sell ratings00

BLU analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

Revenue Next Year

EPS This Year

EPS Next Year

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BLU EPS of $ for the current fiscal year, based on estimates from 0 analysts. The BLU revenue forecast is for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

BLU 股价预测由两类独立数据源支撑:来自 6 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。BLU 的共识目标价为 $14.75(+0.1% 上行空间),分析师共识为 Hold。

BLU 的短期预测(明日)为 $14.77(+0.20%)。

BELLUS Health Inc. 在 NASDAQ 上市,代码 BLU。BLU 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 33% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

BLU 预测 · 8 个问题

根据 6 位华尔街分析师,BLU 的 12 个月平均目标价为 $14.75,最高 $14.75、最低 $14.75。若有图表,中位目标价可在上方查看。相对当前价 $14.74,隐含约 +0.1% 的上行空间。

BLU 目标价BLU 分析师目标价BLU 12个月目标价目标价 BLU

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.